An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions

Por Dekker, Lennard J. M., Zeneyedpour, Lona, Brouwer, Eric, van Duijn, Martijn M., Sillevis Smitt, Peter A. E., Luider, Theo M.
Publicado em 2010

Differential Expression of Splicing Variants of the Human Caldesmon Gene (CALD1) in Glioma Neovascularization versus Normal Brain Microvasculature

Por Zheng, Ping-Pin, Sieuwerts, Anieta M., Luider, Theo M., van der Weiden, M., Sillevis-Smitt, Peter A.E., Kros, Johan M.
Publicado em 2004

Circulating glioma biomarkers

Por Kros, Johan M., Mustafa, Dana M., Dekker, Lennard J.M., Sillevis Smitt, Peter A.E., Luider, Theo M., Zheng, Ping-Pin
Publicado no Neuro Oncol (2015)

Detection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous System

Por van Coevorden-Hameete, Marleen H., Titulaer, Maarten J., Schreurs, Marco W. J., de Graaff, Esther, Sillevis Smitt, Peter A. E., Hoogenraad, Casper C.
Publicado no Front Mol Neurosci (2016)

Proteomics Comparison of Cerebrospinal Fluid of Relapsing Remitting and Primary Progressive Multiple Sclerosis

Por Stoop, Marcel P., Singh, Vaibhav, Dekker, Lennard J., Titulaer, Mark K., Stingl, Christoph, Burgers, Peter C., Sillevis Smitt, Peter A. E., Hintzen, Rogier Q., Luider, Theo M.
Publicado em 2010

Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis

Por de Bont, Judith M., Kros, Johan M., Passier, Monique M.C.J., Reddingius, Roel E., Sillevis Smitt, Peter A.E., Luider, Theo M., den Boer, Monique L., Pieters, Rob
Publicado em 2008

Three sensitive assays do not provide evidence for circulating HuD-specific T cells in the blood of patients with paraneoplastic neurological syndromes with anti-Hu antibodies

Por de Jongste, Adriaan H.C., de Graaf, Marieke T., Martinuzzi, Emanuela, van den Broek, Patricia D.M., Kraan, Jaco, Lamers, Cor H.J., Mallone, Roberto, Gratama, Jan W., Sillevis Smitt, Peter A.E.
Publicado em 2012

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study

Por Taal, Walter, Segers-van Rijn, Joyce M. W., Kros, Johan M., van Heuvel, Irene, van der Rijt, Carin C. D., Bromberg, Jacoline E., Sillevis Smitt, Peter A. E., van den Bent, Martin J.
Publicado em 2012

Addition of serum-containing medium to cerebrospinal fluid prevents cellular loss over time

Por de Graaf, Marieke T., van den Broek, Patricia D. M., Kraan, Jaco, Luitwieler, Ronald L., van den Bent, Martin J., Boonstra, Joke G., Schmitz, Paul I. M., Gratama, Jan W., Sillevis Smitt, Peter A. E.
Publicado em 2011

The clinical spectrum of Caspr2 antibody–associated disease

Por van Sonderen, Agnes, Ariño, Helena, Petit-Pedrol, Mar, Leypoldt, Frank, Körtvélyessy, Peter, Wandinger, Klaus-Peter, Lancaster, Eric, Wirtz, Paul W., Schreurs, Marco W.J., Sillevis Smitt, Peter A.E., Graus, Francesc, Dalmau, Josep, Titulaer, Maarten J.
Publicado no Neurology (2016)

Standardized test for anti-Tr/DNER in patients with paraneoplastic cerebellar degeneration

Por Probst, Christian, Komorowski, Lars, de Graaff, Esther, van Coevorden-Hameete, Marleen, Rogemond, Veronique, Honnorat, Jerome, Sabeter, Lidia, Graus, Francesc, Jarius, Sven, Voltz, Raymond, Wildemann, Brigitte, Franciotta, Diego, Blöcker, Inga M., Schlumberger, Wolfgang, Stöcker, Winfried, Sillevis Smitt, Peter A.E.
Publicado no Neurol Neuroimmunol Neuroinflamm (2015)

Quantitative Proteomics and Metabolomics Analysis of Normal Human Cerebrospinal Fluid Samples*

Por Stoop, Marcel P., Coulier, Leon, Rosenling, Therese, Shi, Shanna, Smolinska, Agnieszka M., Buydens, Lutgarde, Ampt, Kirsten, Stingl, Christoph, Dane, Adrie, Muilwijk, Bas, Luitwieler, Ronald L., Sillevis Smitt, Peter A. E., Hintzen, Rogier Q., Bischoff, Rainer, Wijmenga, Sybren S., Hankemeier, Thomas, van Gool, Alain J., Luider, Theo M.
Publicado em 2010

Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic F...

Por Erdem-Eraslan, Lale, Gravendeel, Lonneke A., de Rooi, Johan, Eilers, Paul H.C., Idbaih, Ahmed, Spliet, Wim G.M., den Dunnen, Wilfred F.A., Teepen, Johannes L., Wesseling, Pieter, Sillevis Smitt, Peter A.E., Kros, Johan M., Gorlia, Thierry, van den Bent, Martin J., French, Pim J.
Publicado em 2013

First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response

Por Taal, Walter, Dubbink, Hendrikus J., Zonnenberg, Chris B.L., Zonnenberg, Bernard A., Postma, Tjeerd J., Gijtenbeek, Johanna M.M., Boogerd, Willem, Groenendijk, Floris H., Kros, Johan M., Kouwenhoven, Mathilde C.M., van Marion, Ronald, van Heuvel, Irene, van der Holt, Bronno, Bromberg, Jacoline E.C., Sillevis Smitt, Peter A.E., Dinjens, Winand N.M., van den Bent, Martin J.
Publicado em 2011